The University of Edinburgh has developed a new method of screening for polymorphs and solvates of drug compounds that has potential to revolutionise the way polymorph screening is conducted. More
LPCN 1002 is a branded product for female hormonal disorders currently in Phase I studies specifically targeting Endometrial hyperplasia and secondary amenorrhea. More